Here are Tuesday's biggest analyst calls: Nvidia, Tesla, Uber, Lemonade, Eli Lilly, Amazon, Align Technology & more

Here are the biggest calls on Wall Street on Tuesday: Morgan Stanley reiterates Nvidia as overweight Morgan Stanley says Nvidia laid out a “winning strategy” at its GTC Conference on Monday. “The central message is that NVIDIA based inference has clear cost per token leadership that gets better with Rubin, and our checks agree. Financial commentary positive but understated, which we like. Reiterate Top Pick.” Deutsche Bank reiterates Uber as buy Deutsche says it’s bullish on the company’s partnership with Nvidia. " Uber 's newly announced expansion of its partnership with NVIDIA represents, in our view, yet another milestone that formalizes and meaningfully scales their prior agreement." BMO initiates Navan at outperform BMO sees a compelling risk/reward for the travel company. “We initiate coverage of Navan ( NAVN) at Outperform with a $13 target price.” Read more. Needham reiterates Amazon as buy Needham says Amazon is best positioned for AI. “Since AMZN owns the largest product catalog, fulfillment network, pricing data, reviews, consumer purchase information, and merchant relationships, AI agents will become an additional source of demand feeding AMZN’s backend, aiding its rev growth, we believe.” Morgan Stanley upgrades Lemonade to overweight from equal weight The bank says it likes the company’s partnership with Tesla. “Lemonade’s Tesla partnership represents an important first step and gives Lemonade first-mover advantage in data analysis and on-the-ground experience. While Lemonade is offering a 50% discount on auto insurance when full self-driving (FSD) is engaged in Tesla vehicles, the company is maintaining underwriting discipline based on the quotes we viewed.” Read more. Wells Fargo upgrades Dover to overweight from equal weight Wells says the industrial conglomerate is well positioned during the Middle East war. “If conflict persists, DOV has limited Middle East exposure, pricing power for any inflationary pressure, dry powder for share repo, and limited AI disruption risk if that thematic overhang continues.” Barclays upgrades Align Technology to overweight from equal weight Barclays says the dental company is too attractive to ignore. “The Middle East conflict has triggered a 15% pullback from the recent Feb high, improving the risk/reward. Admittedly, if the conflict drags on, our call may prove to be premature. However, trading at 10x EBITDA, we believe ALGN is well positioned to benefit post-conflict. PT $200.” Read more. Raymond James upgrades W.P. Carey to outperform from market perform Raymond James says shares of the real estate company are attractive. “Upgrading WPC to Outperform from Market Perform. Re-loaded balance sheet should support investment volume upside in 2026. Attractive investment spreads, low cost of capital (issuing debt in Europe).” HSBC downgrades Eli Lilly to reduce from hold HSBC says weight loss drugs have a smaller total addressable market than investors believe. “We downgrade Lilly t o Reduce (from Hold) as we cut our medium-term forecasts for the market, resulting in our revised target price of USD850 (from USD1,070). We think Lilly shares are priced to perfection, are uncomfortable with working capital trends, and think medium-term earnings trends are optimistic.” Citi upgrades Latam Airlines to buy from neutral Citi says the airline is best positioned for oil market turbulence. “Oil prices remain volatile and the situation fluid, but the initial shock looks well priced for Latin Airlines, and we see carriers better positioned than in 2022 to face higher fuel. LATAM i s apparently the least exposed, followed close by Copa, while Aeromexico and Volaris have may face bigger challenges ahead.” Stifel upgrades Icohr Holdings to buy from hold Stifel says the fluid delivery subsystems company is accelerating. “Exiting last year, we expected 2026 would be a transitional year for Ichor. Yet it has subsequently become clear that cyclical business conditions are not only strengthening, but accelerating.” Raymond James upgrades MSCI to strong buy from outperform The investment bank says the company has limited AI risk. “We are upgrading shares of MSCI to Strong Buy from Outperform; it is our top pick within our Information Services coverage. Our thesis is: (1) Sales momentum has positively inflected; (2) MSCI faces very limited AI risk; (3) the company and its CEO are putting their money where their mouth is.” Morgan Stanley reiterates Tesla as overweight Morgan Stanley says Tesla’s semi’s manufacturing ambitions is still “years away.” “A s Tesla expands its AI ambitions across FSD, robotaxi, and eventually Optimus, access to AI compute is increasingly emerging as a potential constraint. In our view, any move toward internal capacity would be aimed at supporting these in-house initiatives or related parties, rather than external entities.”